A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results